A Computational Exploration of the Molecular Network Associated to Neuroinflammation in Alzheimer's Disease.
Alzheimer disease
cytokines
interleukins
microglia
neurodegenerative diseases
neuroinflammation
toll-like receptors
tumor necrosis factor-alpha
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
11
2020
accepted:
29
06
2021
entrez:
2
8
2021
pubmed:
3
8
2021
medline:
3
8
2021
Statut:
epublish
Résumé
Neuroinflammation, as defined by the presence of classically activated microglia, is thought to play a key role in numerous neurodegenerative disorders such as Alzheimer's disease. While modulating neuroinflammation could prove beneficial against neurodegeneration, identifying its most relevant biological processes and pharmacological targets remains highly challenging. In the present study, we combined text-mining, functional enrichment and protein-level functional interaction analyses to 1) identify the proteins significantly associated to neuroinflammation in Alzheimer's disease over the scientific literature, 2) distinguish the key proteins most likely to control the neuroinflammatory processes significantly associated to Alzheimer's disease, 3) identify their regulatory microRNAs among those dysregulated in Alzheimer's disease and 4) assess their pharmacological targetability. 94 proteins were found to be significantly associated to neuroinflammation in Alzheimer's disease over the scientific literature and IL4, IL10 and IL13 signaling as well as TLR-mediated MyD88- and TRAF6-dependent responses were their most significantly enriched biological processes. IL10, TLR4, IL6, AKT1, CRP, IL4, CXCL8, TNF-alpha, ITGAM, CCL2 and NOS3 were identified as the most potent regulators of the functional interaction network formed by these immune processes. These key proteins were indexed to be regulated by 63 microRNAs dysregulated in Alzheimer's disease, 13 long non-coding RNAs and targetable by 55 small molecules and 8 protein-based therapeutics. In conclusion, our study identifies eleven key proteins with the highest ability to control neuroinflammatory processes significantly associated to Alzheimer's disease, as well as pharmacological compounds with single or pleiotropic actions acting on them. As such, it may facilitate the prioritization of diagnostic and target-engagement biomarkers as well as the development of effective therapeutic strategies against neuroinflammation in Alzheimer's disease.
Identifiants
pubmed: 34335238
doi: 10.3389/fphar.2021.630003
pii: 630003
pmc: PMC8319636
doi:
Types de publication
Journal Article
Langues
eng
Pagination
630003Informations de copyright
Copyright © 2021 El Idrissi, Gressier, Devos and Belarbi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int Immunol. 2006 Aug;18(8):1315-25
pubmed: 16798838
Int J Mol Sci. 2019 Apr 19;20(8):
pubmed: 31010119
Brain Res. 1997 Sep 12;768(1-2):279-86
pubmed: 9369326
N Engl J Med. 2013 Jan 10;368(2):117-27
pubmed: 23150934
J Neuroimmunol. 2002 Mar;124(1-2):83-92
pubmed: 11958825
J Neuroinflammation. 2012 May 25;9:99
pubmed: 22632257
J Neuroinflammation. 2011 Jan 13;8(1):3
pubmed: 21232086
F1000Res. 2018 Jun 14;7:
pubmed: 31489175
Neurosci Lett. 1994 Aug 15;177(1-2):23-6
pubmed: 7824175
Nat Genet. 2013 Dec;45(12):1452-8
pubmed: 24162737
BMC Syst Biol. 2015 Jun 06;9:26
pubmed: 26048415
Eur J Immunol. 2014 Jul;44(7):2085-95
pubmed: 24723426
Neurosci Lett. 1988 Sep 12;91(3):259-64
pubmed: 2972943
Genome Biol. 2013 Jul 29;14(7):R78
pubmed: 23895045
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
Sci Rep. 2015 Sep 03;5:13281
pubmed: 26335098
Neuron. 2010 Oct 6;68(1):19-31
pubmed: 20920788
J Neurosci. 2008 Jan 30;28(5):1213-23
pubmed: 18234899
J Immunol. 2009 Oct 1;183(7):4666-74
pubmed: 19752235
Syst Rev. 2015 Jan 14;4:5
pubmed: 25588314
PLoS One. 2020 Mar 23;15(3):e0229819
pubmed: 32203525
Neurology. 2018 Aug 28;91(9):e867-e877
pubmed: 30054439
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1002-7
pubmed: 24371310
Nucleic Acids Res. 2020 Jan 8;48(D1):D148-D154
pubmed: 31647101
J Neural Transm (Vienna). 2012 Jul;119(7):789-97
pubmed: 22488444
Genome Med. 2019 Dec 3;11(1):78
pubmed: 31796060
Brain Pathol. 2009 Jul;19(3):392-8
pubmed: 18637012
Brain Res. 1993 Dec 3;629(2):245-52
pubmed: 7509248
J Clin Invest. 2003 Aug;112(3):415-22
pubmed: 12897209
Nat Rev Neurol. 2018 Jan;14(1):22-39
pubmed: 29242522
Neuropharmacology. 2004 Mar;46(3):404-11
pubmed: 14975696
CNS Neurol Disord Drug Targets. 2014;13(9):1542-58
pubmed: 25106635
Front Immunol. 2020 Apr 23;11:724
pubmed: 32391019
Int J Mol Sci. 2018 May 30;19(6):
pubmed: 29848996
J Neurosci. 2017 May 17;37(20):5155-5171
pubmed: 28442538
J Alzheimers Dis. 2005 Feb;7(1):63-80
pubmed: 15750215
Behav Brain Res. 2016 Sep 15;311:384-391
pubmed: 27265784
J Neuroinflammation. 2012 Jul 02;9:151
pubmed: 22747753
Mol Neurobiol. 2019 Sep;56(9):6156-6167
pubmed: 30734227
Nucleic Acids Res. 2018 Jan 4;46(D1):D1068-D1073
pubmed: 29156001
Science. 2016 May 6;352(6286):712-716
pubmed: 27033548
Nat Commun. 2017 Jan 23;8:14188
pubmed: 28112148
J Immunol. 2017 Jun 15;198(12):4659-4671
pubmed: 28507030
Nat Commun. 2014 Jun 09;5:3979
pubmed: 24909122
Trends Immunol. 2016 Oct;37(10):668-679
pubmed: 27616557
Neural Regen Res. 2019 Sep;14(9):1594-1602
pubmed: 31089059
Arch Neurol. 2010 Dec;67(12):1473-84
pubmed: 20697030
Brain Res. 2003 Nov 28;992(1):53-9
pubmed: 14604772
Am J Geriatr Psychiatry. 2016 Oct;24(10):903-12
pubmed: 27591915
Int J Mol Sci. 2019 Jan 30;20(3):
pubmed: 30704100
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Front Cell Neurosci. 2019 Jul 18;13:309
pubmed: 31379503
Nat Rev Drug Discov. 2018 May;17(5):317-332
pubmed: 29472638
PLoS One. 2013 Aug 14;8(8):e72744
pubmed: 23967336
Am J Physiol Renal Physiol. 2009 Sep;297(3):F646-52
pubmed: 19570880
Science. 2014 Apr 18;344(6181):310-3
pubmed: 24744378
BMC Bioinformatics. 2017 Mar 2;18(1):142
pubmed: 28249561
J Exp Med. 1991 Mar 1;173(3):699-703
pubmed: 1997652
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503
pubmed: 31691815
J Neuroinflammation. 2012 May 29;9:106
pubmed: 22642825
J Pathol. 2011 Sep;225(1):54-62
pubmed: 21598254
Pharmacol Biochem Behav. 2014 Sep;124:373-9
pubmed: 25038445
Sci Rep. 2017 May 10;7(1):1663
pubmed: 28490734
Oncotarget. 2017 Feb 21;8(8):13690-13702
pubmed: 28099146
Int J Mol Sci. 2018 Nov 30;19(12):
pubmed: 30513656
PLoS One. 2017 Jul 28;12(7):e0182019
pubmed: 28753652
Gene Ther. 2012 Jul;19(7):724-33
pubmed: 21918553
Neurosci Lett. 2020 Sep 25;736:135279
pubmed: 32726591
Neurobiol Aging. 2019 Apr;76:125-132
pubmed: 30711675
Neuroscience. 2012 Apr 5;207:243-60
pubmed: 22342341
J Neuroimmunol. 2001 Feb 1;113(1):49-62
pubmed: 11137576
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
PLoS Comput Biol. 2016 Nov 30;12(11):e1005017
pubmed: 27902695
Neuropharmacology. 2018 Aug;138:151-159
pubmed: 29885420
Nat Genet. 2019 Mar;51(3):404-413
pubmed: 30617256
J Neuroinflammation. 2012 Jan 25;9:23
pubmed: 22277195
Postepy Hig Med Dosw (Online). 2017 Mar 2;71(0):137-148
pubmed: 28258674
PLoS One. 2011;6(9):e24716
pubmed: 21980353
Brain. 2017 Mar 1;140(3):792-803
pubmed: 28122877
Ther Adv Musculoskelet Dis. 2010 Oct;2(5):271-8
pubmed: 22870453
Nature. 2010 Nov 11;468(7321):253-62
pubmed: 21068834
Clin Exp Pharmacol Physiol. 2005 Dec;32(12):1097-103
pubmed: 16445576
Cytotherapy. 2019 Jun;21(6):671-682
pubmed: 31076196
Nucleic Acids Res. 2019 Jan 8;47(D1):D140-D144
pubmed: 30380072
Stroke. 2005 Dec;36(12):2637-41
pubmed: 16269641
J Alzheimers Dis. 2017;60(4):1365-1377
pubmed: 29036818
Nat Genet. 2009 Oct;41(10):1094-9
pubmed: 19734903
Physiol Rev. 2018 Apr 1;98(2):813-880
pubmed: 29488822
Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2417-26
pubmed: 18931031
Curr Neurovasc Res. 2013 Feb;10(1):76-80
pubmed: 23151073
CNS Neurol Disord Drug Targets. 2013 Sep;12(6):870-81
pubmed: 23469836
Arch Neurol. 2006 Apr;63(4):538-43
pubmed: 16606766
Curr Drug Targets. 2016;17(1):111-21
pubmed: 26112047
PLoS One. 2012;7(1):e30525
pubmed: 22303443
Brain. 2018 Sep 1;141(9):2740-2754
pubmed: 30052812
Brain Behav Immun. 2020 Aug;88:844-855
pubmed: 32222525
Hum Genomics. 2019 Nov 7;13(1):55
pubmed: 31699147